你即將離開本站

並前往https://pubmed.ncbi.nlm.nih.gov/30993651/

Lenvatinib: A Review in Hepatocellular Carcinoma - PubMed

Lenvatinib (Lenvima ® ) is an oral small molecule inhibitor of multiple receptor tyrosine kinases, and is approved for the first-line treatment of patients ...

確定！ 回上一頁

查詢 「Lenvatinib」的人也找了：

  1. lenvatinib機轉
    2.
  2. lenvatinib價格
    3.
  3. lenvatinib健保價
    4.
  4. lenvatinib仿單
    5.
  5. lenvatinib健保
    6.
  6. lenvatinib藥廠
    7.
  7. lenvatinib副作用
    8.
  8. lenvatinib標靶
    9.